Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion

Kumiko Nakahira1, Akihiro Morita, Nam-Soon Kim

  • 1Department of Developmental Medicine, Research Institute, Osaka Medical Center for Maternal and Child Health, Izumi, Osaka, Japan.

Plos One
|October 25, 2013
PubMed

Insights

Lymphocyte-specific protein tyrosine kinase (LCK) upregulates Forkhead Box P3 (FOXP3) via tyrosine phosphorylation. This interaction suppresses cancer malignancy by reducing MMP9, SKP2, and VEGF-A expression and inhibiting cellular invasion.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Immunology

Background:

  • Forkhead Box P3 (FOXP3) is a transcription factor crucial for T-regulatory cells and acts as a tumor suppressor.
  • Cancer malignancy is associated with lymphocyte-specific protein tyrosine kinase (LCK).
  • The interaction between FOXP3 and LCK in cancer is not well understood.

Purpose of the Study:

  • To investigate the relationship between FOXP3 and LCK in the context of cancer malignancy.
  • To elucidate the mechanism by which LCK affects FOXP3 activity and downstream targets.
  • To determine the role of LCK-mediated phosphorylation of FOXP3 in regulating cancer-associated genes and invasion.

Main Methods:

  • Identification of LCK as a binding partner of FOXP3.
  • Immunoprecipitation and in vitro kinase assays to confirm LCK phosphorylation of FOXP3 at Tyr-342.
  • Functional assays using wild-type FOXP3 and a Y342F mutant to assess effects on MMP9, SKP2, VEGF-A expression, and cellular invasion in MCF-7 cells.

Main Results:

  • LCK was identified as a binding partner of FOXP3.
  • LCK phosphorylates FOXP3 at Tyr-342, which is essential for FOXP3's ability to suppress MMP9 expression and cellular invasion.
  • LCK-induced upregulation of FOXP3 leads to decreased expression of MMP9, SKP2, and VEGF-A, and suppressed cellular invasion.

Conclusions:

  • LCK upregulates FOXP3 through tyrosine phosphorylation at Tyr-342.
  • This LCK-FOXP3 interaction suppresses key genes (MMP9, SKP2, VEGF-A) involved in cancer malignancy and reduces cellular invasion.
  • Understanding this mechanism offers potential for novel therapeutic strategies against cancer.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K